http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108936689-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0b617d5fd35fcbcc07f1d769ca16034 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-17 |
| filingDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cddec9e3da2f021f170b0d49a0710c61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c7c470a2dc8975aa91153a31b7c8381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe46003ca84a56aaded75f0d2d51ff9 |
| publicationDate | 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108936689-A |
| titleOfInvention | Oral liquid for regulating immunity and preparation method thereof |
| abstract | The invention discloses an oral liquid for regulating immunity and a preparation method thereof. Each 10000ml oral liquid is composed of the following components: 200-600g of ovalbumin powder, 470-870g of calcium lactate, 100-500g of calcium gluconate, and 10 g of taurine ‑40g, white sugar 800‑1600g, lactic acid 5‑25ml, the rest is purified water; with egg white protein powder, calcium lactate, calcium gluconate and taurine as raw materials, white sugar and lactic acid as auxiliary materials, the taste is good, especially For young children, it is easy to accept, and the compliance of taking is better; and through the combination of various components of the oral liquid, the synergistic effect complements each other, which can not only improve the non-specific immunity of the human body, but also improve the specific immunity. It has antibacterial and antiviral capabilities and diverse efficacy, and it is also of positive significance for reducing the risk of disease for people with low immunity, reducing social medical costs and improving social production efficiency. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112545984-A |
| priorityDate | 2018-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.